My plan is to develop a program where people with type 1 diabetes feel they have a clinic that cares about them as a person. I want to help my patients adapt their regimen to their changing lifestyle. In addition to developing the clinic dedicated to type 1 diabetes, we will create community-based activities and programs. Our goal is to have networking opportunities throughout the Columbus area for people with type 1 diabetes and their families.
I believe in personalizing my care approach to help patients adapt to life with diabetes, rather than only focusing on long-term glucose levels (A1C values), prescriptions and a quick discharge. I think it's important to help people understand the reality of living with type 1 diabetes.
Although I’m new to Ohio State, I'm enjoying the experience so far, especially working with all of my colleagues. I also work with diabetic students on campus, through Ohio State's active chapter of the College Diabetes Network.
In my free time, I enjoy traveling and attending Ohio State football games and I am also a huge soccer fan.
- American Association of Clinical Endocrinology (ACEE) National Board of Directors, 2011-present
- Juvenile Diabetes Research Foundation (JDRF) Career Development Award, 1999
- National Lipid Associated (NLA) National Board of Directors, 2011-2014
University of Chicago, Pritzker School of Medicine
Baylor College of Medicine Medical Center
7/1/1991 - 6/23/1993
Specialties and conditions I treat
- Endocrinology, Diabetes & Metabolism
Locations where I practice
More about my work
Endocrinology Diabetes Metabolism
University of Texas Southwestern Medical Center
7/1/1993 - 6/30/1998
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Endocrinology, Diabetes & Metabolism)
Endocrinology and Metabolism
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies, etc. because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Wyne has reported financial relationships with the medical device, research and/or drug companies, etc. listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Akcea Therapeutics